ADIPOQ and Insulin resistance: Low circulatory levels of adiponectin contribute to insulin resistance and endothelial vascular dysfunction (Goldstein & Scalia, 2004), which could be involved in AF pathogenesis (Abed & Wittert, 2013; Goudis et al., 2015; O'Neal et al., 2014).